May 26, 2026

@michaelokun

What is in the Parkinson’s drug pipeline and why should folks care? A clinical trial pipeline refers to the therapies currently being tested in human studies to determine safety and effectiveness before approval. Buff and colleagues describe in a new paper in the Journal of Parkinson’s Disease how the Parkinson’s drug pipeline evolved between 2015-2024 and where the field may be heading next. Key Points: - Researchers identified 444 Parkinson’s drug trials over a 10-year period, including therapies targeting symptoms and disease modification. - The pipeline is shifting beyond dopamine and now includes immune therapies, GLP-1 drugs, stem cells, gene therapies and alpha-synuclein targeted approaches. - There are now more disease-modifying trials than ever before, however there is still no proven therapy that slows or stops Parkinson’s progression. My take: This paper captures both the excitement and the frustration of the current moment in Parkinson’s research. We are finally seeing therapies aimed at biology beyond dopamine, and many of these approaches are more personalized and mechanism driven. At the same time, the pipeline reminds us how hard Parkinson’s disease is to tackle. The future will likely require smarter biomarkers, better patient selection and combination therapies aimed at multiple pathways simultaneously. Here are 5 points that resonated w/ me: 1- Dopamine therapies still matter and continue to improve quality of life for many folks living w/ Parkinson’s. 2- Stem cell therapies and gene therapies are moving from science fiction toward real human testing. 3- Alpha-synuclein, LRRK2 and GBA are emerging as some of the most important biologic targets in the pipeline. 4- Non-motor symptoms like constipation, depression, sleep and cognition remain major unmet needs in Parkinson’s care. 5- The future may not be one miracle drug, but instead a combination of precision therapies matched to the right person at the right stage of disease. https://journals.sagepub.com/doi/full/10.1177/1877718X261454154 #parkinson